 WATERTOWN, Mass.--BUSINESS WIRE--SQZ Biotechnologies Company NYSE: SQZ, a cell therapy company developing novel treatments for multiple therapeutic areas, today reported financial results for the period ended March 31, 2021 and reviewed recent business highlights. We continue to execute across our broad and differentiated cell therapy pipeline and are excited by the potential patient impact of these programs to treat cancer, autoimmune, and infectious diseases, said Armon Sharei, Ph.D., C 